• Indivior Pharmaceuticals Chief Scientific Officer Christian Heidbreder sold 18,586 common shares on July 10, 2026 at USD 41.14.
• Heidbreder’s direct holding fell to 209,337 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002014639-26-000011), on July 13, 2026, and is solely responsible for the information contained therein.